补体调节失调是长期COVID的一个普遍且在治疗上可接受的特征
Kirsten Baillie1, Helen E Davies2, Samuel B K Keat1
1Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK.
长期COVID患者表现出补充激活标记的升高,这表明补充系统在病情中发挥了作用. 这些生物标志物可以帮助用现有的补充抑制剂诊断和治疗长期COVID.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 系统生物学 系统生物学
背景情况:
- 长期COVID呈现出SARS-CoV-2感染后的各种持续症状,其生物学基础不清楚.
- 在急性COVID-19中已知有补充系统失调,但在长期COVID中未经检查.
- 了解长期COVID机制对于诊断和治疗至关重要.
研究的目的:
- 研究补充系统激活和调节在长期COVID中的作用.
- 确定长期COVID诊断的潜在生物标志物.
- 探索长期COVID的治疗目标.
主要方法:
- 从长期COVID患者和健康康复者的血中量化补充蛋白和激活/调节标志物.
- 采用了样本组的年龄,种族,性别,感染和疫苗匹配.
- 在生物标志物分析中采用了通用线性建模.
主要成果:
- 在长期COVID患者中显著增加经典,替代和终端补充通路激活标记.
- 四个标记物 (iC3b,TCC,Ba,C5a) 的组合显示,长期COVID的预测能力为0.785.
- 其他补充蛋白和调节剂也显示了群体之间的定量差异.
结论:
- 补充生物标志物显示出促进长期COVID诊断的潜力.
- 补充激活抑制剂可能为长期COVID提供治疗策略.
- 这项研究强调了补充系统在长期COVID病原发生过程中的参与.
更多相关视频
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Humoral Immune Responses
Depression: Overview
